ACC Issues Expert Guidance for Cardiovascular Sequelae After SARS-CoV-2 Infection
The American College of Cardiology has published guidelines for managing adult patients with cardiovascular sequelae after COVID-19 infection.
The American College of Cardiology has published guidelines for managing adult patients with cardiovascular sequelae after COVID-19 infection.
In this ninth update to the living guideline on COVID-19 therapeutics, the World Health Organization evaluates the use of nirmatrelvir/ritonavir for nonsevere COVID-19 and revises prior recommendations regarding the use of remdesivir.
The American College of Physicians provides an overview of the final update to the rapid, living practice points on the use of remdesivir for the treatment of COVID-19 infection.
The American College of Physicians has released version 2 of their rapid, living practice points to summarize currently available evidence on the antibody response and natural immunity conferred by prior COVID-19 infection.
The World Health Organization assess the use of Janus kinase inhibitors and monoclonal antibodies in the seventh update of their living guideline on COVID-19 therapeutics.
Based on the most recent available literature, the EULAR updated the points-to-consider on using immunomodulatory therapies in COVID-19, from a rheumatology perspective.
The CDC has also updated the recommended quarantine period for individuals exposed to someone with COVID-19.
Updates include recommendation to provide all sexually active patients with information about PrEP, use of cabotegravir injections for PrEP.
Experts from the Infectious Diseases Society of America provide updated guidelines for clinicians on COVID-19 prevention.
Researchers provide guidance on the techniques, tools, and resources that should be considered for the development and implementation of e-learning programs for microbiology and infectious diseases.